December 15, 2004
For Immediate Release
FOOTHILL RANCH, CA -- MedMarket Diligence and Medical Technology Partners Release Report on the Top Volume Inpatient and Outpatient Cardiovascular Procedures
This report presents detailed inpatient and outpatient procedure data on the highest volume cardiovascular procedures. The data in this report has been an invaluable component of MedMarket Diligence's cardiovascular device technology analyses, and is now available as a separate report.
The report presents a ranking of the top cardiovascular procedures by volume, with detailed data from Medicare, the National Hospital Discharge Survey, the Healthcare Cost and Utilization Project, Data is presented on discharges by payer (Medicare, Medicaid, Blue Cross/Blue Shield, other private insurance, self-pay, no charge, uninsured, other), age group (<1, 1-17, 18-44, 45-64, 65-84 and >85) and U.S. geographic region (midwest, northeast, south, west).
Drawn from multiple federal and other sources, including the National Hospital Discharge Survey, the Healthcare Cost and Utilization Project, and Medicare, among others, and combined with the reimbursement consulting-driven insights of Medical Technology Partners, the report provides a comprehensive, multiple-year assessment of the trend in procedure volume and reimbursement for the top cardiovascular procedures.
Further details on the Top Volume Cardiovascular Proceures report are available at www.mediligence.com/rpt-td301.htm or by contacting Patrick Driscoll at (949) 859-3401, e-mail.
The Cardiovascular Procedures report is based on TrueData(TM) Reports from MedMarket Diligence and Medical Technology Partners. Standard, off-the-shelf reports are priced based on procedures being identified by conventionally used names and/or the use of multiple similar ICD-9, CPT-4 or DRG codes.
While the full spectrum of medical/surgical procedures may be presented in individual TrueData(TM) Reports, examples of reports available include:
TrueData(TM) reports can be put to a wide range of uses, including:
· Hospital selection for clinical trials.
· Trends in payer mix, age distribution and regional distribution reveal opportunities and challenges for product development and sales.
· Top volume hospitals by region reveal untapped market potential in specific sites. This data enables the Sales department to target their sales force and objectively evaluate sales performance.
· Strategic planning for new product launch or selection of test markets for new products.
· Trends in the aggregate U.S. volume of procedures illustrate the net effect of changes in clinical practice and technology utilization, revealing opportunities or challenges for market growth.
A particularly valuable component of TrueData(TM) Reports is data on the top hospitals by region performing each medical/surgical procedure, revealing real opportunities for the marketing and sales of medical products.
The TrueData Reports are described in detail at www.mediligence.com/truedata.htm, including sample data. Multiple options are available for the reports with pricing based on detail required and numbers of procedure reports ordered.
About Medical Technology Partners
Medical Technology Partners helps companies understand and work with the new reimbursement realities within the health care marketplace by way of reasonable and functional strategies and plans. MTP is committed to excellent customer service, advancing patient care, making timely and accurate recommendations, and reasonable and flexible pricing arrangements. President Jerry Stringham has spent much of the past sixteen years as a reimbursement strategy consultant. Beginning in December 1988, Mr. Stringham began providing reimbursement consulting to diverse medical and pharmaceutical companies. Mr. Stringham holds a BS in Mechanical Engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School. He has been part of five medical device start-up organizations operating out of New England. Mr. Stringham founded Medical Technology Partners in 1998 to fill the growing need for business-oriented reimbursement consulting. Mr. Stringham's experience in industry, including as a Principal in the health economics practice of a major CRO, brings expertise to new technology reimbursement challenges.
About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the “MedMarkets” newsletter, a monthly analysis of the market implications of new medical technology and dedicated reports on technology markets. For more information on MedMarket Diligence, LLC, contact Patrick Driscoll at (949) 859-3401, e-mail, or visit http://www.mediligence.com.